Last reviewed · How we verify
EnBrace HR (COCARBOXYLASE)
EnBrace HR works by converting vitamin B12 into its active form, which is necessary for various bodily functions.
At a glance
| Generic name | COCARBOXYLASE |
|---|---|
| Sponsor | Jaymac Pharmaceuticals, LLC |
| Drug class | Methylating Agent [EPC] |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Mechanism of action
MECHANISM OF ACTION: Vitamin B 12 [ TREATMENT ]; FOLATE [ PREVENTION ]; OTHER [ SUPPLEMENTATION ];
Approved indications
- vitamin B 12 deficiency
- vitamin B 12 -cofactor deficiency
- l-methylfolate deficiency
- pregnancy-related vitamin B 9 deficiency
- pregnancy-related vitamin B 12 deficiency
Common side effects
- Diarrhea
- Polycythemia vera
- Itching
- Transitory exanthema
- Feeling of swelling of entire body
- Allergic sensitization
Key clinical trials
- Evaluation of an ATP-Containing Parenteral Vitamin B Complex in Patients With Symptomatic Diabetic Polyneuropathy (PHASE4)
- Co-administration of Thiamine Pyrophosphate and Metformin in Type 2 Diabetes (NA)
- Cocarnit Effects on Macrophages Polarization (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |